A case of erenumab, a new migraine medication, and delayed wound and bone healing after foot and ankle surgery
Patient selection and optimization are crucial components of successful surgery outcomes. Erenumab is a Calcitonin Gene-Related Peptide (CGRP) antagonist that was recently approved by the FDA for the treatment of migraines. CGRP is a neuropeptide implicated in migraines, but is also essential in ost...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Foot & Ankle Surgery: Techniques, Reports & Cases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S266739672400082X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|